GlassScriptPhysician profile
Mark C Sturdivant
NPI 1841277654
$2,470.58
in general payments reported to CMS, 2019-2025
22 companies · $424 in 2025
The $424 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $689 · 2020: $166 · 2021: $339 · 2022: $350 · 2023: $304 · 2024: $199 · 2025: $424.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $867 · Entertainment: $59.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $866.74 |
| Entertainment | $59.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $513.12 | 2019-2023 | Puraply |
| Aroa Biosurgery Incorporated | $494.09 | 2019-2025 | |
| Smith+Nephew, INC. | $309.88 | 2019-2024 | Renasys Go V2 Home, Grafix Pl, Oasis |
| Checkpoint Surgical, INC | $219.44 | 2021-2022 | |
| Integra Lifesciences Corporation | $192.30 | 2019-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Musculoskeletal Transplant Foundation INC. | $153.95 | 2019-2023 | |
| Amniox Medical, INC. | $113.07 | 2019 | |
| Boston Scientific Corporation | $84.42 | 2023-2025 | Varithena Administration Pack |
| Melinta Therapeutics, LLC | $62.43 | 2019 | |
| Covidien LP | $55.56 | 2019 | |
| Solventum Corporation | $38.16 | 2024 | Activ.A.C., 3m Coban |
| Urgo Medical North America, LLC | $31.73 | 2023-2024 | Urgok2, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4 |
| Next Science LLC | $26.25 | 2023 | Xperience, Blastx, Surgx |
| Ethicon US, LLC | $24.65 | 2019 | |
| Medela LLC | $23.19 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Reddress USA, INC. | $21.92 | 2024 | |
| Bioventus LLC | $21.81 | 2022 | |
| Convatec INC. | $20.82 | 2022 | |
| Kci USA, INC. | $18.94 | 2023 | Promogran Prisma, Kerramax Care, Activ.A.C. |
| Allergan, INC. | $16.16 | 2019 | |
| Paratek Pharmaceuticals, INC. | $15.09 | 2024 | Nuzyra |
| Hartmann USA, INC. | $13.60 | 2025 | Zetuvit Plus 10x10 P10 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Sturdivant listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.